42 stories from 15 sources

Fauci invokes Fifth amid Medicare and vaccine funding battles

Day’s Recap

Supporting Articles

11:04 PMAl Jazeera

Why did Anthony Fauci invoke the Fifth Amendment? Senate hearing explained

Summary

Anthony Fauci invoked the Fifth Amendment during a Senate hearing as Republican lawmakers questioned him about his role in the COVID-19 response. The amendment protects witnesses from being compelled to give answers that could be self-incriminating.

Fauci's refusal to answer specific questions shifts the hearing from policy scrutiny toward possible legal

Why it matters

The invocation raises the legal stakes around pandemic decisions while leaving the underlying factual disputes unresolved.

Link to Story

2:34 PMAl Jazeera

Dr Anthony Fauci pleads the Fifth at Covid hearing

Summary

Anthony Fauci declined to answer questions at a Senate hearing on the origins of the Covid-19 pandemic by invoking his Fifth Amendment rights. The hearing focused on disputed questions surrounding the pandemic's origins.

Fauci's refusal prevents senators from obtaining direct answers while giving critics new political material about

Why it matters

The testimony dispute will deepen political battles over Covid policy and the government's handling of pandemic evidence.

Link to Story

1:59 PMFinancial Times

Fauci invokes Fifth Amendment at fiery Senate hearing on Covid-19

Summary

Anthony Fauci invoked his Fifth Amendment rights during a contentious Senate hearing on the Covid pandemic. He also accused a Republican senator of pursuing an unhinged fixation against him.

Fauci's refusal to answer increases the political pressure surrounding Republican claims about Covid's origins and

Why it matters

The hearing turns Fauci's testimony into a political and legal confrontation over pandemic responsibility.

Link to Story

1:58 PMBBC

Anthony Fauci refuses to answer questions during tense US Senate hearing about Covid origins

Summary

Anthony Fauci declined to answer Senate questions on Covid origins, citing the Fifth Amendment and concern that Republicans would use testimony to pursue perjury charges. The standoff left lawmakers without on-the-record answers while intensifying partisan claims about accountability.

The decisive shift is the move from oversight to legal jeopardy as the organizing frame

Why it matters

Once witnesses expect prosecution risk, Congress’s ability to extract facts in public hearings collapses.

Link to Story

5:00 AMNPR Politics

Anthony Fauci invokes Fifth Amendment in Rand Paul Senate hearing

Summary

Anthony Fauci is set to testify at a Senate hearing where Rand Paul is expected to press him on COVID-19 origins and pandemic-era decision-making. Paul has publicized Fauci's schedules and records to argue for deeper scrutiny.

The fight moved from media sparring to a formal Senate forum with documents in play.

Why it matters

Congressional theater here can become concrete constraints on how the U.S. funds, regulates, and communicates science in the next crisis.

Link to Story

5 stories · 4 sources

5:27 PMFortune

RFK says he found Fauci’s diary in government archives as Fauci invokes the Fifth Amendment over 100 times

Summary

Robert F. Kennedy Jr. said he found Anthony Fauci's diary in government archives as Fauci repeatedly invoked the Fifth Amendment during questioning about COVID-19's origins. Rand Paul's panel plans to vote next week on whether to hold Fauci in contempt for refusing to answer.

The next decisive step is the contempt vote, which could turn the dispute into a

Why it matters

The contempt vote could determine whether the COVID-origins investigation gains enforcement power or remains a partisan inquiry.

Link to Story

8:26 PMAl Jazeera

Trump cuts WHO off from Gavi vaccine alliance funding

Summary

The Trump administration cut U.S. funding for Gavi, the global vaccine alliance, amid its broader conflict with the World Health Organization and related United Nations health institutions. The decision threatens a major source of support for international immunization programs.

The funding cutoff shifts the immediate burden of vaccine financing onto Gavi and other donors,

Why it matters

A funding gap in Gavi's programs could reduce childhood vaccination coverage and increase the risk of preventable outbreaks.

Link to Story

2:06 PMMarketWatch

Rising Medicare Part D premiums could drive more people into Medicare Advantage plans

Summary

Medicare Advantage plans could gain enrollment if the administration ends a program that has helped hold down premiums for Medicare Part D prescription drug plans. Higher Part D costs may push beneficiaries to compare alternatives more aggressively.

Ending the subsidy program would make stand-alone prescription coverage less attractive for some Medicare beneficiaries.

Why it matters

A prescription-drug policy change could accelerate the shift from traditional Medicare toward privately administered Medicare Advantage plans.

Link to Story

10:58 AMStat News

STAT+: End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs

Summary

The White House decision to end a Medicare drug subsidy is poised to increase out-of-pocket costs for some beneficiaries and gives Democrats a new line of attack on prescription affordability ahead of midterms. The change reshapes messaging around who is responsible for higher drug bills.

Ending the subsidy shifts immediate cost exposure onto seniors, even if the policy rationale is

Why it matters

Prescription costs are a top voter concern, and Medicare changes can move both turnout and persuasion.

Link to Story

11:29 AMMarketWatch

Medicare is about to change a drug program that held down the cost of premiums. Here’s what to know.

Summary

Medicare is changing a prescription drug program that helped keep premiums down. Analysts expect the shift to raise premiums for some beneficiaries and accelerate movement into Medicare Advantage plans.

Premium stabilization is weakening as Medicare rewires the mechanism that spread drug costs across plans.

Why it matters

Small program design changes in Part D can quickly reshape premiums, plan competition, and where seniors get coverage.

Link to Story

4:30 PMCNBC

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

Summary

The FTC sued Hims and Hers over alleged sharing of health data with Meta and Snap, as well as billing practices and subscription cancellations. The company’s shares fell 10% after the action.

The lawsuit turns Hims and Hers’ growth model into a regulatory liability, with scrutiny focused

Why it matters

Telehealth companies could face broader enforcement if regulators treat targeted advertising and difficult cancellations as consumer-protection violations.

Link to Story

2:45 PMStat News

STAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuit

Summary

The FTC sued Hims and Hers, alleging that the telehealth company misled consumers and violated their privacy. The case adds federal enforcement pressure to the company’s marketing and data practices.

The allegations put the company’s customer-acquisition strategy under direct scrutiny, particularly how it represents services

Why it matters

The case tests how aggressively regulators will police privacy and marketing claims in direct-to-consumer telehealth.

Link to Story

10:34 AMGothamist

Researchers find alarming rates of mental decline, warn of 'dementia crisis' in Newark area

Summary

A Rutgers led survey in the Newark area found unusually high rates of cognitive decline among older residents, many in public or subsidized housing. Researchers warn the findings point to an emerging dementia burden that local systems are not prepared to manage.

The decisive shift is evidence of potentially concentrated dementia prevalence in a high need urban

Why it matters

If dementia is clustering in under resourced communities, local health systems will face a cost and capacity shock with few near term clinical fixes.

Link to Story

10:59 AMCNBC

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Summary

Shareholders allege Novo Nordisk misled investors about the tolerability profile of CagriSema, after clinical trial results disappointed and the company’s market value fell sharply. The lawsuit centers on whether disclosures about side effects and patient dropouts matched what the company knew.

The tolerance and persistence bar for obesity drugs is rising as competition tightens. Novo is

Why it matters

Obesity drug valuations and adoption hinge on tolerability, and legal pressure can reshape how companies report and market trial outcomes.

Link to Story

4:00 AMPYMNTS

Hospitals Can’t Outsource AI Accountability

Summary

Hospitals are moving from testing whether AI works to confronting who is liable when AI-driven tools fail across clinical decision support, patient communications, and administrative workflows. The piece argues that responsibility cannot be shifted to vendors as AI becomes embedded in care delivery and operations.

Accountability is shifting from experimentation to enforceable responsibility as AI enters higher-stakes clinical use. Health

Why it matters

Hospitals that treat AI as a plug-in service risk absorbing patient-safety failures and regulatory exposure without the controls to prevent them.

Link to Story

8:35 AMScienceDaily

Scientists find a simple way to stop cavities without drilling

Summary

A large U.S. trial found that silver diamine fluoride, applied as a quick liquid, stopped decay in more than half of treated baby teeth without drilling, anesthesia, or sedation. The tradeoff is permanent dark staining of the decayed area.

Caries treatment can shift from surgical workflows to office or community-based application. Young children, especially

Why it matters

A low-friction, low-cost intervention could reduce pain, infections, and operating-room dental procedures for kids.

Link to Story

Other Developments

A curated list of other prominent stories from this day.

7:55 PMBloomberg Markets

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Summary

Teva Pharmaceuticals CEO Richard Francis discussed the company’s positive second-quarter earnings, its drug pipeline, the expected effects of changing Medicare rules on patients, and Teva’s new direct listing on the New York Stock Exchange.

Teva is pairing stronger recent performance with a market-access shift and a higher-profile US listing.

Why it matters

Teva’s outlook now depends on both drug development and how Medicare policy reshapes its commercial market.

Link to Story

11:08 AMNYT New York

Dentists in Brooklyn Exploited Patients in Pain, Lawsuit Charges

Summary

New York City sued two Brooklyn dental practices, alleging that they steered patients toward high-interest loans and falsely claimed that some procedures were not covered by insurance.

The alleged scheme targeted patients facing urgent dental care who had limited ability to challenge

Why it matters

The lawsuit tests whether dental practices can use medical urgency and confusing payment terms to push patients into costly debt.

Link to Story

7:44 PMScienceDaily

Daily multivitamin may help older adults stay independent

Summary

A preliminary study found that older adults taking a daily multivitamin reported better functional health after three years than those taking a placebo. The findings have not yet undergone peer review.

The reported benefit concerns everyday function, not proof that multivitamins prevent disability or extend life.

Why it matters

A low-cost intervention could have broad implications for healthy aging, but the evidence is not yet strong enough to support a policy shift.

Link to Story

6:17 PMFortune

Dr. Fauci, the Lockdown Czar, just won’t go away

Summary

The article revisits a scientific literature review and meta-analysis on COVID-19 lockdowns conducted by the author and two colleagues. It argues that Fauci did not adequately engage with their conclusions.

The central dispute is over how policymakers weighed evidence on lockdown effectiveness and harms during

Why it matters

The debate affects how governments balance disease control, economic disruption, and civil liberties in the next public-health emergency.

Link to Story

5:53 PMBloomberg Markets

Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO

Summary

Attovia Therapeutics, an early-stage biotech developing treatments for immune-mediated diseases, is seeking to raise up to $212.5 million through a US initial public offering.

Attovia’s proposed IPO tests investor appetite for high-risk biotech assets despite the company’s early development

Why it matters

The offering will show whether public markets are again willing to finance speculative drug developers at scale.

Link to Story

5:47 PMFortune

Beyond the Covid origins: Fauci’s pandemic diary reveals a starstruck Julia Roberts and Trump gasping for oxygen

Summary

Newly released pages from Anthony Fauci’s pandemic diary describe President Donald Trump’s temperature reaching 103°F and his struggle to breathe, prompting Mark Meadows to seek Fauci’s advice about Trump’s return to public life. The diary also includes Fauci’s account of meeting actress Julia Roberts.

The records add detail to how serious Trump’s illness was and show Fauci advising the

Why it matters

The diary provides a contemporaneous record of the medical and political pressure surrounding Trump’s Covid treatment.

Link to Story

5:00 PMStat News

STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx

Summary

Latigo Biotherapeutics reported positive mid-stage results for an acute-pain drug designed to compete with Vertex’s Journavx. The data support further development of another non-opioid treatment option.

The results strengthen competition in a market seeking alternatives to opioids, but they do not

Why it matters

A successful rival could expand non-opioid pain treatment and pressure Vertex on pricing and market share.

Link to Story

3:29 PMGothamist

What does it take to get NYC buildings to test for disease-causing Legionella?

Summary

New York City officials say publicizing noncompliant buildings on the Upper East Side helped spur testing for Legionella, the bacteria linked to Legionnaires’ disease. The approach shows how officials are pressing building owners to follow disease-prevention measures.

Public disclosure has become a practical enforcement tool where voluntary compliance falls short. The city’s

Why it matters

Preventing Legionnaires’ disease depends on reaching private building owners before contaminated systems create an outbreak.

Link to Story

12:18 PMCNBC

Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line

Summary

Humana beat quarterly expectations and kept its 2026 adjusted profit outlook at at least $9 per share, citing medical costs that remain within its assumptions. Some investors expected an upward revision and reacted to the unchanged guidance as underwhelming.

The key signal is cost trend stability, not upside surprise. Medicare Advantage economics hinge on

Why it matters

Insurer profitability affects Medicare Advantage benefits, premiums, and how aggressively plans manage care.

Link to Story

11:17 AMBloomberg Markets

Humana Lower on Profit Guidance; P&G Moves on Results | Stock Movers

Summary

Humana held its annual profit guidance despite a strong second quarter, weighing on the insurer's shares. P&G offered a cautious fiscal-year outlook after quarterly results missed estimates, while Kering rallied on better-than-expected Gucci revenue.

The market is rewarding evidence of stabilization at Gucci while penalizing cautious guidance and earnings

Why it matters

Guidance and brand-level performance are driving fashion and consumer-stock valuations more than headline quarterly revenue.

Link to Story

11:07 AMMarketWatch

I got an unexpected $1,000 medical bill. Here’s why I’m not paying it yet.

Summary

The piece argues patients should not immediately pay surprise medical bills and should first verify charges, coding, and insurance adjudication. It lays out steps to request itemized bills, compare explanations of benefits, and negotiate or dispute errors.

The decisive shift is treating medical bills as negotiable and frequently incorrect, not as final

Why it matters

Small process steps can prevent unnecessary out-of-pocket spending and expose systemic billing errors at scale.

Link to Story

10:59 AMHousing Wire

Vital Infrastructure REIT Buys East New York Outpatient Facility for $90M

Summary

Vital Infrastructure Property Trust bought the 142,249-square-foot East New York Health Hub at 101 Pennsylvania Avenue in Brooklyn for $89.9 million. The property is leased as an outpatient facility to AdvantageCare Physicians.

Institutional capital is moving deeper into outpatient real estate tied to long-term leases. That shifts

Why it matters

Ownership changes in outpatient facilities can reshape clinic economics and stability for providers and patients in a high-need neighborhood.

Link to Story

9:00 AMVariety

Michael J. Fox Will Be Honored With TV Academy’s Bob Hope Humanitarian Award at the Emmys

Summary

Michael J. Fox will receive the Television Academy’s Bob Hope Humanitarian Award at this year’s Emmys for his work advancing Parkinson’s disease research and advocacy. The honor adds a major philanthropic recognition to his long-standing television legacy.

The Television Academy is using a prime, widely viewed platform to elevate Fox’s Parkinson’s work

Why it matters

A major Emmy-stage humanitarian honor can translate celebrity recognition into real-world funding and momentum for disease research.

Link to Story

1:35 AMScienceDaily

Can’t sleep in the heat? These 8 tricks could save your night

Summary

Practical steps like limiting indoor heat gain, timing ventilation for cooler outdoor air, and using lighter bedding and fans can improve sleep during heatwaves. The guidance emphasizes preventing the home from overheating and using cooling strategies safely.

Hot nights are becoming a recurrent health stressor, not an occasional inconvenience. Poor sleep compounds

Why it matters

Sleep disruption is a common and preventable pathway from heat exposure to real health harm.

Link to Story

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!